Atossa Genetics Inc, a clinical-stage biopharmaceutical company headquartered in Seattle, Washington, is dedicated to advancing innovative therapies for breast cancer and infectious diseases. The company's pipeline features key product candidates designed to tackle significant unmet medical needs in oncology, utilizing cutting-edge drug delivery systems and novel formulations. With a strong focus on enhancing patient outcomes through targeted treatments, Atossa is strategically positioned to lead in pharmaceutical innovation within an evolving healthcare landscape.